Yuji Oe
Tohoku University
45 Papers
46 Citations
Yuji Oe is an academic researcher from Tohoku University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 36 publications. Previous affiliations of Yuji Oe include Japan Society for the Promotion of Science.
Chat about Author
Papers
Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease
Koichi Kikuchi,Daisuke Saigusa,Yoshitomi Kanemitsu,Yotaro Matsumoto,Paxton Thanai,Naoto Suzuki,Koki Mise,Hiroaki Yamaguchi,Tomohiro Nakamura,Kei Asaji,Chikahisa Mukawa,Hiroki Tsukamoto,Toshihiro Sato,Yoshitsugu Oikawa,Tomoyuki Iwasaki,Yuji Oe,Tomoya Tsukimi,Noriko N. Fukuda,Hsin Jung Ho,Fumika Nanto-Hara,Jiro Ogura,Ritsumi Saito,Shizuko Nagao,Yusuke Ohsaki,Satoshi Shimada,Takehiro Suzuki,Takafumi Toyohara,Eikan Mishima,Hisato Shima,Yasutoshi Akiyama,Yukako Akiyama,Mariko Ichijo,Tetsuro Matsuhashi,Akihiro Matsuo,Yoshiaki Ogata,Ching Chin Yang,Chitose Suzuki,Matthew C. Breeggemann,Jurgen Heymann,Miho Shimizu,Susumu Ogawa,Nobuyuki Takahashi,Takashi Suzuki,Yuji Owada,Shigeo Kure,Nariyasu Mano,Tomoyoshi Soga,Takashi Wada,Jeffrey B. Kopp,Shinji Fukuda,Atsushi Hozawa,Masayuki Yamamoto,Sadayoshi Ito,Jun Wada,Yoshihisa Tomioka,Takaaki Abe +55 more
TL;DR: It is shown that phenol sulfate, a gut microbiota-derived metabolite, is increased in diabetic kidney disease and contributes to the pathology by promoting kidney injury, suggesting phenyl sulfate could be used a marker and therapeutic target for the treatment of diabetic kidneys disease.
Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease
Emiko Sato,Takefumi Mori,Takefumi Mori,Eikan Mishima,Arisa Suzuki,Sanae Sugawara,Naho Kurasawa,Daisuke Saigusa,Daisuke Miura,Tomomi Morikawa-Ichinose,Ritsumi Saito,Ikuko Oba-Yabana,Ikuko Oba-Yabana,Yuji Oe,Kiyomi Kisu,Eri Naganuma,Kenji Koizumi,Takayuki Mokudai,Yoshimi Niwano,Tai Kudo,Chitose Suzuki,Nobuyuki Takahashi,Hiroshi Sato,Takaaki Abe,Toshimitsu Niwa,Sadayoshi Ito +25 more
TL;DR: The results indicate that indoxyl sulfate is a pathogenic factor for sarcopenia in CKD, which is associated with increased morbidity and mortality in chronic kidney disease.
Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy.
Yuji Oe,Sakiko Hayashi,Tomofumi Fushima,Emiko Sato,Kiyomi Kisu,Hiroshi Sato,Sadayoshi Ito,Nobuyuki Takahashi +7 more
TL;DR: It is concluded that enhanced FXa and PAR2 exacerbate DN and that both are promising targets for preventingDN and that Alleviating inflammation is probably more important than inhibiting coagulation per se when treating kidney diseases using anticoagulants.
87
Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia.
Feng Li,Tomofumi Fushima,Gen Oyanagi,H. W. Davin Townley-Tilson,Emiko Sato,Hironobu Nakada,Yuji Oe,John R. Hagaman,Jennifer Wilder,Manyu Li,Akiyo Sekimoto,Daisuke Saigusa,Hiroshi Sato,Sadayoshi Ito,J. Charles Jennette,Nobuyo Maeda,S. Ananth Karumanchi,Oliver Smithies,Nobuyuki Takahashi +18 more
TL;DR: Dietary nicotinamide, a nonteratogenic amide of vitamin B3, improves the maternal condition, prolongs pregnancies, and prevents FGR in two contrasting mouse models of PE, and is shown to benefit both dams and pups.
64
Protease-activated receptor 2 exacerbates adenine-induced renal tubulointerstitial injury in mice.
Sakiko Hayashi,Yuji Oe,Tomofumi Fushima,Emiko Sato,Hiroshi Sato,Sadayoshi Ito,Nobuyuki Takahashi +6 more
TL;DR: The data indicate that PAR2 is critically important in the pathogenesis of adenine-induced tubular injury and PAR2 antagonists under development could be useful to treat and prevent CKD.
26